Methods of treating disorders with glycosylation defective proteins
AssigneeCase Western Reserve University
InventorsKumar N. Alagramam, Suhasini Gopal
Life of this patent
Estimating the term…
Abstract
A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
Claims22
A method of treating a glycosylation-defective protein associated disease or disorder in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
A method of treating a sensory deficit in a subject associated with a mutation of the human clarin-1 protein hCLRN1 protein, the method comprising:
- administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
A method of treating Usher syndrome type III (USH3) in a subject, the method comprising:
- administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
Dependencies are inferred from the claim text.